Jazz Pharmaceuticals (JAZZ): Q4 EPS of $1.17 beats by $0.08. Revenue of $83.5M (+56.4% Y/Y)...

|About: Jazz Pharmaceuticals, Inc. (JAZZ)|By:, SA News Editor
Jazz Pharmaceuticals (JAZZ): Q4 EPS of $1.17 beats by $0.08. Revenue of $83.5M (+56.4% Y/Y) beats by $3M. Shares +2.3% AH. (PR)